Medtronic

Medtronic

Medical device maker advancing therapies

Global Product Manager - NPD

Full-TimeUpdated on 9/30/2026Deadline 10/2/26
$133.6k - $200.4k/yr

+ Short-term incentive plan

Mid
Bachelor's, Master's, MBA, PhD
Mounds View, MN, USA+1 more

More locations: Newton, MA, USA

Hybrid

At least four days on-site per week required.

No H1B Sponsorship

About the job

Requirements
  • Requires mastery of a specialty area and full knowledge of industry practices, typically obtained through advanced education combined with experience.
  • Requires a baccalaureate degree and at least 7 years of relevant experience, or an advanced degree and at least 5 years of relevant experience.
  • Bachelor’s degree in engineering, science, business, clinical, healthcare, biomedical, or a related field.
  • At least 5 years of work experience in marketing, strategy, business, and/or sales operations.
  • At least 3 years of product management experience in a commercial medical device setting.
  • Experience defining and applying secondary research, primary qualitative research, and primary quantitative research techniques to identify and address customer insights using clinical data.
  • Ability to develop relationships and collaborate with Marketing, Clinical, Research and Development, Health Economics, Sales, and other stakeholders.
  • Ability to drive communications strategies and influence stakeholders without direct authority.
  • Experience with market and revenue modeling.
  • Experience in clinical and/or product marketing.
  • Specific medical device experience in electrophysiology.
  • Ability to work independently and collaboratively to meet deadlines.
  • Ability to travel up to 20%, including international travel, for trade shows, internal meetings, and customer programs.
  • Previous clinical support or mapping experience.
  • Experience engaging physicians and key opinion leaders.
  • Experience launching single-use devices and capital products.
Responsibilities
  • Formulate and review short- and long-range plans, goals, and objectives for a product or product line to define and maintain its vision, strategy, and roadmap.
  • Conduct competitive product analysis and market research of consumer behavior and professional audiences.
  • Determine the profitability and viability of new products or product enhancements and drive market analysis, segmentation, and positioning development.
  • Identify unmet customer needs and commercial opportunities.
  • Develop product user needs and marketing strategies and tactics for effective product placement across the product life cycle.
  • Lead voice-of-customer and voice-of-business activities, partnering with markets and converting insights into clear product requirements.
  • Work with cross-functional teams to finalize product specifications and align on product definition and development.
  • Serve as a technical adviser by demonstrating products and troubleshooting product issues.
  • Challenge assumptions with global counterparts to refine product decisions.
  • Visit accounts and users to solicit feedback on company products and services.
  • Consolidate and disseminate knowledge of the global electrophysiology ablation landscape by region.
  • Support regional training of marketing and sales teams.
  • Develop and leverage marketing insights for segmentation, product positioning, message development, channel identification, tool creation, and execution.
  • Network with colleagues across divisions and cross-functional departments to align strategies and opportunities.
  • Maintain a primary commitment to patient safety and product quality.
Desired Qualifications
  • Advanced degree including Master of Science, Doctor of Philosophy, or Master of Business Administration.
  • Proven business acumen.
  • Outstanding internal and external customer service skills.
  • Previous clinical support or mapping experience.
  • Proven physician and key opinion leader engagement.
  • Single-use device and capital product launch experience.

About the company

Medtronic makes medical devices and therapies to treat chronic diseases, including implantables, sensors, and diabetes management tools. Its devices interact with the body to regulate or monitor functions, such as pacemakers delivering heart stimulation and neuromodulation devices sending electrical signals. The company differentiates itself through a long history of device development and a broad portfolio, expanded via acquisitions to access new technologies and markets. Its goal is to improve patient health outcomes by providing integrated medical technologies that help manage chronic conditions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Fridley, Minnesota

Founded

1949

Get referred to Medtronic

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 FY27 revenue hit $9.8 billion, up 13.7%, and guidance rose to 7.75%.
  • Cardiovascular grew 18.9%; CRM, diabetes, and pelvic health each posted double-digit growth.
  • FDA cleared Hugo's LigaSure RAS Maryland jaw in September 2026, expanding U.S. instrumentation.

What critics are saying

  • MiniMed still depends on Medtronic until the exchange offer closes in October 2026.
  • Spinal cord stimulator lawsuits continue in 2026 over Intellis and Vanta device failures.
  • A failed MiniMed separation traps capital and erases Medtronic's re-rating story.

What makes Medtronic unique

  • Cardiac Ablation Solutions grew 88% in Q1 FY27, with Sphere-9 gaining U.S. share.
  • Hugo spans 35 countries, and Cornerstone adds Sentire outside the U.S.
  • MiniMed separation unlocks two focused companies after the 2026 IPO and exchange offer.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Health Savings Account/Flexible Spending Account

Unlimited Paid Time Off

Paid Vacation

Paid Sick Leave

Paid Holidays

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Employee Assistance Program

Wellness Program

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↑ 0%
Insider Monkey
Sep 23rd, 2026
Medtronic (MDT): Q1 beat sparks target hikes, but Wall Street splits on re-rating case.

Medtronic (MDT): Q1 beat sparks target hikes, but Wall Street splits on re-rating case. Published September 23, 2026 at 2:08 pm EDT Medtronic plc (NYSE:MDT) drew a broad round of price-target increases after its fiscal 2027 first-quarter results, but Wall Street remains divided over whether accelerating growth can support a meaningful re-rating of the stock. Bull case: growth is broadening. Mizuho raised its target to $115 from $100 and maintained Outperform after Medtronic plc (NYSE:MDT) reported 13.7% organic revenue growth. Analyst Anthony Petrone highlighted roughly 7% organic growth across cardiovascular products, with Cardiac Ablation Solutions and new products driving upside. BofA also raised its target to $110 from $95 with Buy, saying growth drivers are emerging across nearly every business outside CAS. Wells Fargo increased its target to $104 from $102 with Overweight, pointing to the Q1 beat, CAS strength, and potential upside to fiscal 2027 guidance. The results gave those views additional support. The quarter included an extra fiscal week, which Medtronic estimated contributed about $570 million to revenue. Management subsequently raised its fiscal 2027 organic revenue growth outlook to 7.25%-7.75% from 6.75%-7.25%. CAS remained the standout, with revenue up 88%, while CRM, Pelvic Health and diabetes each grew 15%. Management expects CAS to grow more than 2.5 times its market in fiscal 2027. Bear case: growth may not yet merit a re-rating. The more cautious analysts also raised their targets, but their ratings show the remaining debate. Deutsche Bank lifted its target to $92 from $78 with Hold, Truist moved to $99 from $86 with Hold, and Stifel raised its target to $95 from $80 with Hold. Baird raised its target to $100 from $91 with Neutral, acknowledging the impressive growth acceleration but remaining less convinced that Medtronic plc (NYSE:MDT) deserves a higher valuation multiple. BTIG, meanwhile, raised its target to $100 from $91 with Buy but flagged questions around the durability of Hugo following Medtronic's $700 million investment in Cornerstone Robotics. Medtronic plc (NYSE:MDT) is also reinvesting part of its revenue upside into commercial acceleration and M&A. The Cornerstone investment creates foregone interest, while management has increased acquisitions and investments significantly over the past year. Hedge funds add as short interest falls. The institutional picture moved favorably in Q2. First Eagle Investment Management increased its stake 38% to 13.78 million shares, Arrowstreet Capital raised its position 177% to 12.89 million, Citadel added 447% to 5.37 million, D.E. Shaw increased 392% to 4.40 million, and AQR raised its position 103% to 3.30 million. Short interest fell to 12.13 million shares as of August 31 from 18.12 million a month earlier, a decline of about 33%. Short interest represented 0.95% of shares outstanding, with a 1.74-day short ratio. Valuation is the next test. Medtronic plc (NYSE:MDT) traded at a forward P/E of 15.1 as of September 22. The question for Wall Street is whether broader growth can persist beyond CAS and support that valuation. The December 10-11 Investor Day could provide the next major update on the company's longer-term growth trajectory.

Growthmenti
Sep 21st, 2026
How India's PLI scheme is shaping real jobs in 2026.

How India's PLI scheme is shaping real jobs in 2026. Discover which sectors the PLI scheme truly fuels, the roles emerging today, and actionable steps to land those jobs. Introduction. India's Production-Linked Incentive (PLI) scheme has become the backbone of the country's industrial revival. While headlines often tout trillion-rupee investments, job-seekers wonder: what roles are actually being created?* This post breaks down the sectors where PLI incentives are translating into concrete employment, illustrates real-world examples, and gives you a roadmap to tap into these opportunities. 1. Manufacturing gets a talent boost. The original PLI focus - electronics, telecom equipment, and automotive components - has moved beyond capital spending to human capital. * - Electronics assembly hubs such as Foxconn's* new plant in Tamil Nadu now employ 1,800 line-workers, quality engineers, and supply-chain analysts. * - EV battery manufacturers like Exide Industries* and Tata Power* have expanded their R&D teams, hiring 250 battery chemists, data scientists, and safety engineers in the past year. * - White-goods PLI has spurred LG Innova* to open a smart-appliance factory in Gujarat, creating 400 roles ranging from CNC machinists to IoT software testers. What this means for you: The demand is not just for manual labor; firms need technical specialists who can manage advanced automation, quality control, and digital twins. Upskilling in PLC programming, robotics, and data analytics can make you a prime candidate. 2. Renewable Energy & Green manufacturing. In 2026, the PLI extension for solar PV modules and wind turbine components is delivering jobs that align with India's climate goals. * - Adani Green* commissioned a solar-cell line in Madhya Pradesh, hiring 300 production engineers and 150 maintenance technicians. * - Vestas India* opened a blade-fabrication unit in Karnataka, creating 200 roles for composite material experts and CAD designers. * - Ancillary services - logistics, warehouse management, and quality assurance - have added another 500 jobs across the supply chain. Action tip: If you have a background in mechanical engineering, materials science, or supply-chain logistics, consider short certification courses in solar PV design or wind turbine maintenance offered by NPTEL and the Indian Institute of Technology (IIT) platforms. 3. Pharma & medical devices - A hidden growth engine. The pharma PLI scheme, originally aimed at generic drug production, now fuels a surge in high-skill roles. * - Cipla* expanded its API (Active Pharmaceutical Ingredient) plant in Hyderabad, hiring 120 process engineers and 80 regulatory affairs specialists. * - Medtronic India* leveraged the medical-device PLI to set up a manufacturing unit for cardiac implants in Maharashtra, creating 250 positions for biomedical engineers and quality auditors. * - The ecosystem of contract research organizations (CROs) has grown, adding 400 jobs for clinical data managers and biostatisticians. Takeaway: Regulatory knowledge (USFDA, CDSCO) and expertise in Good Manufacturing Practices (GMP) are premium skills. Enroll in a GMP certification or a short-term regulatory affairs program to stay competitive. 4. Defence & aerospace - The new frontier. The defence-manufacturing PLI, launched in 2024, is now delivering tangible employment outcomes. * - Bharat Electronics* set up a radar-system assembly line in Delhi, employing 180 electronics engineers and 70 system-integration specialists. * - Hindustan Aeronautics* expanded its UAV production in Pune, creating 220 roles for aerospace designers, test pilots, and avionics software developers. * - Supporting industries - metal-fabrication, precision machining, and cybersecurity - have added 300 indirect jobs. Practical step: Defence projects often require security clearances. Begin the clearance process early, and consider a short course in defence procurement offered by the Institute of Defence Studies and Analyses (IDSA). 5. Digital services embedded in physical goods. A less obvious but rapidly growing area is the convergence of digital services with PLI-enabled products. * - Samsung*'s smart-home appliance line integrates AI voice assistants. The company hired 150 AI-model trainers and 80 data-privacy analysts in Bangalore. * - Mahindra & Mahindra*'s electric tractors now come with telematics dashboards, creating demand for IoT firmware engineers and field data analysts. * - Start-ups like Ather Energy* are outsourcing software development to TCS* and Infosys*, adding 200 fresh graduate positions for full-stack developers. How to act: Strengthen your full-stack development or AI/ML skill set. Platforms like Growthmenti offer curated learning paths aligned with these emerging roles. 6. Skill-Mapping & immediate actions for job-seekers. Understanding the macro-trend is only half the battle. Here's a checklist you can implement today: * - Identify your target sector (e.g., EV batteries, solar PV, pharma). Use the Ministry of Commerce's PLI dashboard to see which states have active incentives. * - Map required skills - cross-reference job postings on Naukri, LinkedIn, and Indeed with the roles listed above. Note recurring keywords such as PLC programming*, GMP*, IoT*, or regulatory affairs*. * - Enroll in micro-credentials - pick one certification that fills the biggest gap (e.g., Robotics Process Automation* from IIT Bombay, Solar PV Design* from NPTEL). * - Network strategically - join sector-specific LinkedIn groups (e.g., India EV Manufacturing*), attend virtual webinars hosted by the Confederation of Indian Industry (CII), and reach out to alumni from companies hiring under PLI. * - Build a project portfolio - for technical roles, create a GitHub repo or a CAD showcase that mirrors a real-world problem (e.g., designing a low-cost solar inverter). * - Tailor your resume - highlight any experience with government incentives, compliance, or cost-optimization projects; these resonate strongly with PLI-driven employers. Conclusion. The PLI scheme is no longer a buzzword; it is a job-creation engine reshaping India's employment landscape across manufacturing, renewable energy, pharma, defence, and digital-embedded services. By aligning your skill set with the sectors that are actually hiring, you can ride the wave of growth in 2026 and beyond. Ready to act? Visit Growthmenti's career-path tool, upload your resume, and get a personalized roadmap to the PLI-driven roles that match your profile. Your next opportunity could be just a certification away.

The Healthcare Technology Report
Sep 21st, 2026
Medtronic expands surgical Robotics portfolio in $700 million Cornerstone partnership.

Medtronic expands surgical Robotics portfolio in $700 million Cornerstone partnership. Published. September 21, 2026 Medtronic is making an approximately $700 million investment as part of a partnership with Cornerstone Robotics that will add the Sentire surgical system to its robotic-assisted surgery portfolio and give it distribution rights in select markets outside the U.S. Sentire will be distributed alongside Medtronic's Hugo robotic-assisted surgery system where Cornerstone's platform is approved, giving Medtronic a two-platform portfolio for multi-port robotic surgery. Global adoption of robotic-assisted surgery remains in the single digits, according to Medtronic. Hugo is already used in more than 35 countries across six continents, with total procedures expected to exceed 50,000 globally by the end of the company's fiscal year. Matt Anderson, Senior Vice President and President of Surgical at Medtronic, said surgeons, health systems and markets have "varying needs and preferences," driving the company's investment across robotic platforms and related technologies. Sentire received CE Mark approval in May 2026 for minimally invasive general, gynecologic, thoracic and urologic procedures and has market approval in China and Singapore. Its design includes an immersive console with dual-console capability. Cornerstone founder and CEO Samuel Au said physicians and patients would be the "greatest beneficiaries" as the partnership expands access. Medtronic plans to continue developing Hugo through software upgrades, real-time artificial intelligence, integrated stapling, expanded instrumentation and additional clinical indications.

InsuranceAsia News
Sep 18th, 2026
Envest, Labuan Re, Allianz Commercial, Willis: 14 APAC insurance people moves of the week.

Envest, Labuan Re, Allianz Commercial, Willis: 14 APAC insurance people moves of the week. InsuranceAsia News wraps up the people moves from the insurance industry in Asia this week. 1. Envest taps former Marsh NZ chief to lead New Zealand broking. The Envest Group has appointed Toni Ferrier as chief executive officer of Envest Broking New Zealand, effective February 2027. Envest Group chief executive Greg Mullins said Ferrier's appointment represents a significant milestone in the group's long-term growth strategy in New Zealand. Ferrier was most recently CEO of Marsh New Zealand, and was previously president of Marsh Risk New Zealand. She stepped down from her Marsh role last month. Read the full story here. 2. Labuan Re hires CUO. Malaysian reinsurer Labuan Reinsurance has appointed Chan Swee Chee as CUO, effective from Monday. Chan brings over 28 years of experience in the (re)insurance industry, with extensive expertise in treaty and facultative reinsurance across Asia, including the Middle East. Read the full story here. 3. Allianz Commercial confirms new head of liability underwriting. Steve Williams has been appointed as Allianz Commercial's head of liability underwriting on a permanent basis. Sydney-based Williams has been with Allianz for over 15 years, having spent much of this time in senior underwriting roles in the personal injury division, before stepping into the acting head of liability role in October. Read the full story here. 4. Willis promotes sales head to lead Australia P&C business. Willis has announced the appointment of Will Sare as head of corporate for Australia, effective immediately. Sare, who has been with Willis since July 2025 as head of sales for the Pacific having joined from Marsh, will lead the property and casualty business across Australia. Read the full story here. 5. Aon strengthens Asia transaction solutions team, appoints ART leader. Natsuko Kato has joined Aon's transaction solutions team in Asia as a deputy director based in Japan. Japan-based Kato, who joins from Medtronic Japan, where she served as principal legal counsel, will support Aon's growing M&A insurance practice. Aon has appointed Tanvee Mehta as its alternative risk transfer (ART) leader for Asia. Singapore-based Mehta joins from Swiss Re, where she had been the senior structurer of ART solutions for APAC since 2023. Read the full story here and here. 6. Marsh names cyber managing principal in Australia. Jack Morecroft has joined Marsh as its managing principal for cyber in Australia. Melbourne-based Morecroft joins from Gallagher, where he had been since January 2022 in London and Melbourne. Read the full story here. 7. Howden brings crop, livestock, parametric risk specialist to Singapore. Howden has appointed crop, livestock and parametric risk specialist Sonal Mishra as a senior vice president within its reinsurance division. Mishra has relocated from India to Singapore, having spent the last almost 10 years at Tata AIG General Insurance leading and managing the crop, livestock, and parametric insurance portfolio in her role as associate vice president. Read the full story here. 8. Zurich property, marine head joins Lockton Australia as head of real estate. Evan Moore has joined Lockton Australia as its head of real estate, according to a LinkedIn update. Sydney-based Moore joins from Zurich, where he led property, marine and technical lines for its general insurance business in Australia, after relocating from the UK in February 2023. Read the full story here. 9. Coface names head of commercial for Thailand. Coface has appointed Natthaphan Phanitchawong as its head of commercial for Thailand. Bangkok-based Phanitchawong joins from AIG, where he spent 17 years as the head of the trade credit insurance department. Read the full story here. 10. BMS Group appoints national head of general claims for Australia. BMS Group has appointed Anna Capone as national head of general claims for Australia, according to a LinkedIn update. Perth-based Capone joins after over two and a half years at McLardy McShane Insurance Advisors in Melbourne, where she was most recently national claims manager. Read the full story here. 11. Miller Japan hires business development, credit insurance specialist. Miller Japan has tapped Hiroaki Wakamatsu as a business development and credit insurance specialist. Tokyo-based Wakamatsu will work alongside Tokinori Kono, head of non-marine broking, across multiple lines of business, including credit, surety and political risk. Read the full story here. 12. Starr makes double A&H appointments. Starr has appointed Sharon Ho as head of A&H for Hong Kong. Ho will lead the continued development of Starr's A&H offering in Hong Kong, with a particular focus on growing the travel business across a range of distribution channels. Starr has appointed Patto To as its regional A&H claims manager in Asia. Hong Kong-based To will focus on strengthening Starr's A&H claims service across Hong Kong and Singapore, supporting regional teams, clients and partners. Read the full story here and here. 13. Specialist Risk Group Australia appoints managing partner. Specialist Risk Group Australia has appointed Josh Lauren as managing partner. Perth-based Lauren joins the broker following a year-long career break, having previously worked for Empire Insurance Group, a Western Australia-based broker which was acquired by Marsh in 2024. Read the full story here. 14. Thailand's TQR taps business development assistant vice president. Thai reinsurance broker TQR Public Company has appointed Tanasta Dhadasih as an assistant vice president for business development, focusing on specialty reinsurance, effective from Monday. Bangkok-based Dhadasih brings over 14 years of experience in the insurance industry, with strong expertise in financial lines, underwriting, corporate business, and client management. Read the full story here. Other moves you may have missed. India-focused reinsurer Niyam Group has appointed Aditi Chaturvedi as director of actuarial. She joins from Accenture, where she was an actuarial senior principal for the last four years. Ageas Group's country manager for Malaysia and Singapore Dimitri Terryn confirmed his departure from the firm. He will return to Belgium to join the management team of Ageas Re as chief risk officer. For more InsuranceAsia News (IAN) people moves at brokers, insurers, reinsurers, insurtechs, specialty players, MGAs and loss adjusters across Asia Pacific's fast-growing (re)insurance markets click here. * Gallagher Re, MDS Group, Howden, Bowring Marsh, Charles Taylor: 12 APAC insurance people moves of the week * September 11 Swiss Re, Axa XL, Aviso Specialty, bolttech, Chubb, Markel, IFFCO Tokio General Insurance, Munich Re, Wills Re, Sompo, Coalition Australia, and Ace Insurance Brokers also made personnel changes over the last week. * Marsh Re, Axa XL Re, IFFCO Tokio, Marsh, Zurich: 21 APAC insurance people moves of the week * September 4 Great American Insurance, Sompo, Chubb, Peak Re, Adva Group, Aon, Generali Central Insurance, Scor Business Solutions, Lockton, Aviso Specialty, QBE, Coface, Gallagher, AIG, Ageas Re and 360 Underwriting Solutions also made personnel changes over the last week. * Amwins, Guy Carpenter, Markel, Allianz: 13 APAC insurance people moves of the week * August 28 MSIG, Angel Underwriting, Chubb, Victor Insurance, AIG, McLarens, Lockton, Sompo and Aon also made personnel changes over the last week. * Aon, Zurich, Marsh, AIG, Allianz Trade: 18 APAC insurance people moves of the week * August 21 Nat Re, Oneglobal Broking, Pen Underwriting, Crawford, Berkley Re, Generali Central Insurance, Protec General Insurance, Niyam Group, Gallagher, Cowbell, QBE, HDI Global, Axa XL and Key Insurance Partners also made personnel changes over the last week. Partner Content * BlackRock | Rethink the rules: how TAA and ETFs are reshaping portfolio construction As global markets fragment into distinct regional poles, tactical asset allocation - powered by precise index data and ETF implementation - has become essential for navigating regime shifts and enhancing portfolio resilience. Daniel Caderas, Portfolio Manager, Global Tactical Asset Allocation APAC Lead, BlackRock Raman Aylur Subramanian, Managing Director, Index Research & Development, MSCI Part 1: [...] * BlackRock | Infrastructure comes of age for insurers Are insurers capturing full value from the asset class? BlackRock shares its perspective. * PartnerRe | The missing life stage: why caregiving is reshaping the future of protection in APAC To stay relevant, insurers should engage caregivers earlier with solutions that combine protection, navigation support, and preventative planning. * BHSI | The real risk begins underwater: how subsea risk is changing insurance Asia's subsea industry is expanding and evolving rapidly, with the growing use of technology across the region changing the way risks are be assessed.

PR Newswire
Sep 16th, 2026
Medtronic's LigaSure vessel-sealing tech gets FDA clearance for Hugo robotic surgery system

Medtronic has received FDA clearance for its LigaSure RAS Maryland jaw device on the Hugo robotic-assisted surgery system. The vessel-sealing technology, previously used in over 45 million procedures globally, is now available for robotic-assisted surgery in the US. The instrument seals and cuts vessels up to 7mm in diameter in approximately 2 seconds whilst minimising thermal spread. It works exclusively with the Valleylab FT10 energy platform on the Hugo RAS system. The Hugo RAS system is currently cleared for urologic procedures in the US and is being used in multiple health systems. Medtronic is working to expand its indications to general and gynaecologic procedures. Outside the US, the system has been used in over 50 different surgical procedures across more than 35 countries. The LigaSure RAS Maryland instrument received CE Mark for European use in 2025.